Literature DB >> 18540159

High-performance liquid chromatographic assay for cinnarizine in human plasma.

Hanna Nowacka-Krukowska1, Monika Rakowska, Kinga Neubart, Maria Kobylińska.   

Abstract

The high performance liquid chromatography for the determination of cinnarizine in human plasma is described. The procedure involves liquid-liquid extraction followed by reversed phase high-performance chromatographic analysis with fluorometric detection. The method was validated for accuracy, precision, specificity, linearity, sensitivity, recovery, and stability. No endogenous compounds were found to interfere. The absolute extraction recovery of cinnarizine and clocinizine (internal standard) from plasma samples were 97% and 89%, respectively. The linearity was assessed in the range 1-100 ng/mL. The intra-day and inter-day relative standard deviations were less than 10%, and the accuracy of the assay expressed by bias was in the range 0.14-2.37%. The method was proved to be suitable for human pharmacokinetic studies following single oral dose.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18540159

Source DB:  PubMed          Journal:  Acta Pol Pharm        ISSN: 0001-6837            Impact factor:   0.330


  3 in total

1.  Examining the gastrointestinal transit of lipid-based liquid crystalline systems using whole-animal imaging.

Authors:  Anna C Pham; Tri-Hung Nguyen; Cameron J Nowell; Bim Graham; Ben J Boyd
Journal:  Drug Deliv Transl Res       Date:  2015-12       Impact factor: 4.617

2.  Brief Effect of a Small Hydrophobic Drug (Cinnarizine) on the Physicochemical Characterisation of Niosomes Produced by Thin-Film Hydration and Microfluidic Methods.

Authors:  Li Key Yeo; Temidayo O B Olusanya; Cheng Shu Chaw; Amal Ali Elkordy
Journal:  Pharmaceutics       Date:  2018-10-13       Impact factor: 6.321

3.  Development and Validation of RP-LC Method for the Determination of Cinnarizine/Piracetam and Cinnarizine/Heptaminol Acefyllinate in Presence of Cinnarizine Reported Degradation Products.

Authors:  Ola M El-Houssini; Nagwan H Zawilla; Mohammad A Mohammad
Journal:  Anal Chem Insights       Date:  2013-10-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.